Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E


Autoria(s): Andrieu, C.; Baylot, M.; Bladou, Franck; de Thone, Aurelie; Ettinger, Susan; Fazli, Ladan; Garrido, Carmen; Gleave, Martin; Iovanna, Juan; Nelson, Colleen; Rocchi, Palma; So, Alan; Soubeyran, Philippe; Taieb, David
Data(s)

2010

Identificador

http://eprints.qut.edu.au/47647/

Publicador

Nature Publishing Group

Relação

DOI:10.1038/onc.2009.479

Andrieu, C., Baylot, M., Bladou, Franck, de Thone, Aurelie, Ettinger, Susan, Fazli, Ladan, Garrido, Carmen, Gleave, Martin, Iovanna, Juan, Nelson, Colleen, Rocchi, Palma, So, Alan, Soubeyran, Philippe, & Taieb, David (2010) Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. Oncogene, 29(13), pp. 1883-1896.

Fonte

Faculty of Science and Technology

Palavras-Chave #110300 CLINICAL SCIENCES #111200 ONCOLOGY AND CARCINOGENESIS
Tipo

Journal Article